Retraction Note: Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model

Li-cheng Dai; Xiang Wang; Xing Yao; Li-shan Min; Jin-liang Ping; Jian-fang He

doi:10.1038/s41401-019-0236-6

Retraction Note: Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model

Li-cheng Dai¹, Xiang Wang¹, Xing Yao², Li-shan Min², Jin-liang Ping³, Jian-fang He¹
¹ Huzhou Key Laboratory of Molecular Medicine, Huzhou Central Hospital, Huzhou 313000, China
² Department of General Surgery and Huzhou Central Hospital, Huzhou 313000, China
³ Department of Pathology, Huzhou Central Hospital, Huzhou 313000, China
Correspondence to: Li-cheng Dai: dlc21@126.com,
DOI: 10.1038/s41401-019-0236-6

Advance online: 5 August 2019

Abstract

The Editor has retracted this article [1] because some of the ﬁgures have errors which were introduced during the process of integrating and editing the original images (Figs. 1 and 3). Due to the fact that the research was conducted over ten years ago, the original data can no longer be found, and the article cannot be corrected. All authors agree to this retraction.

Keywords:

Retraction

Retraction Note: Antisense oligonucleotides targeting midkine inhibit tumor growth in an in situ human hepatocellular carcinoma model

Abstract

Article Options

Download Citation

Cited times in Scopus

Share